Audit 324958

FY End
2024-06-30
Total Expended
$72.33M
Findings
0
Programs
31
Year: 2024 Accepted: 2024-10-16

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.493 Congressional Directives $1.89M Yes 0
93.279 Drug Abuse and Addiction Research Programs $696,380 Yes 0
93.361 Nursing Research $374,883 Yes 0
93.397 Cancer Centers Support Grants $368,385 Yes 0
47.070 Computer and Information Science and Engineering $333,925 Yes 0
93.393 Cancer Cause and Prevention Research $304,659 Yes 0
93.855 Allergy, Immunology and Transplantation Research $229,692 Yes 0
93.839 Blood Diseases and Resources Research $175,407 Yes 0
93.121 Oral Diseases and Disorders Research $174,094 Yes 0
12.420 Military Medical Research and Development $124,325 Yes 0
47.049 Mathematical and Physical Sciences $101,417 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $96,041 Yes 0
93.103 Food and Drug Administration_research $95,847 Yes 0
47.084 Nsf Technology, Innovation, and Partnerships $91,649 Yes 0
93.865 Child Health and Human Development Extramural Research $90,790 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $61,585 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $38,692 Yes 0
93.399 Cancer Control $38,135 Yes 0
93.866 Aging Research $36,203 Yes 0
93.396 Cancer Biology Research $31,294 Yes 0
93.172 Human Genome Research $25,793 Yes 0
93.837 Cardiovascular Diseases Research $24,481 Yes 0
93.113 Environmental Health $21,836 Yes 0
93.859 Biomedical Research and Research Training $18,060 Yes 0
93.395 Cancer Treatment Research $15,908 Yes 0
93.307 Minority Health and Health Disparities Research $14,445 Yes 0
93.173 Research Related to Deafness and Communication Disorders $13,929 Yes 0
93.398 Cancer Research Manpower $11,666 Yes 0
93.394 Cancer Detection and Diagnosis Research $2,415 Yes 0
93.242 Mental Health Research Grants $1,993 Yes 0
93.213 Research and Training in Complementary and Integrative Health $1,255 Yes 0

Contacts

Name Title Type
DVHKP4N619V9 Virginia Perez Auditee
8137456498 Richard Sacher Auditor
No contacts on file

Notes to SEFA

Title: NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. he accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. Reporting Entity Uniform Guidance, Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General, set forth the audit and reporting requirements for federal awards and state financial assistance. The Schedule includes all federal and state awards expended by the Cancer Center. Basis of Accounting The Schedule has been prepared using the accrual basis of accounting. The accrual basis of accounting recognizes revenues when they are earned and expenditures when the related liability is incurred.
Title: NOTE 2 - INDIRECT COST RATE Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. The Cancer Center did not use the 10% de minimis indirect cost rate allowed by the Uniform Guidance.
Title: NOTE 3 - CONTINGENCIES Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. Grant monies received and disbursed by the Cancer Center are for specific purposes and are subject to audit by the grantor agencies. Such audits may result in requests for reimbursement due to disallowed expenditures. Based upon prior experience, the Cancer Center does not believe that such disallowances, if any, would have a material effect on the financial position of the Cancer Center. As of September 29, 2024, there were no material questioned or disallowed costs as a result of grant audits in process or completed of which management is aware.